PrecisionLife Announces New Appointments to Launch Diagnostics and Healthcare Strategy | Dr Gerald Dunstan & Hannah Bibby

PrecisionLife®, a leading computational biology company focused on precision medicine in complex chronic diseases, announces the appointment of Dr Gerald Dunstan as SVP Corporate Development and Hannah Bibby as Product Strategy Lead to drive the company’s expansion into precision diagnostics and personalized healthcare.

Gerald Dunstan
Gerald Dunstan As Svp Corporate Development

Gerald joins PrecisionLife as SVP Corporate Development working across both biopharma and healthcare. Gerald is a molecular biologist who received his PhD in Antimicrobial Drug Discovery under the Glaxo Scholarship Program. After several years working across drug discovery and development, Gerald transitioned into commercial roles where he has spent the last 25 years advising biopharma companies, healthcare providers and payers.

He was a junior partner in McKinsey & Company’s healthcare and pharma products practice, and a co-founder and Board member of the McKinsey Hospital Institute. He led KPMG’s Healthcare & Life Sciences strategy practice and business units in Medtronic and GE Healthcare. Prior to joining PrecisionLife, Gerald served as Chief Strategy Officer at Prescient Healthcare Group.

“I’m so impressed by the number and quality of pharma partnerships PrecisionLife has already established, and excited by the potential for so many more across a range of disease areas,” says Gerald. “There is huge untapped potential for the company’s technology and IP to be applied in healthcare, which we’re just starting to explore. It’s hard not to be excited by the impact this could make on the prediction and treatment of complex chronic diseases for patients.”

Hannah Bibby As Product Strategy Lead

Hannah joins PrecisionLife as Product Strategy Lead where she will translate the disease insights generated by the PrecisionLife platform into valuable new healthcare products. Hannah holds a Natural Sciences MA from the University of Cambridge and is completing a Master’s in Biomedical Informatics at Harvard Medical School. She has previously served in Owkin’s Diagnostics Product Strategy team and as Strategy Consultant in L.E.K. Consulting’s life science practice.

“We’re delighted to welcome Gerald and Hannah to the PrecisionLife team at a time when our deep disease insights and patient stratification biomarkers are finding important new markets and bringing precision approaches to the early, more accurate diagnosis and care of patients with complex chronic diseases,” said Dr Steve Gardner, PrecisionLife CEO. “They will drive our collaborations with CROs, diagnostics and healthcare organizations to bring a new generation of simple, cost-effective and highly predictive tests to market in diseases like endometriosis, ME/CFS, long COVID and ALS where there is massive unmet medical need.”

Other Executives In the News

Medical Device News Magazine
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Dr. Val Kolesnitchenko brings extensive ophthalmology experience in clinical practice and industry to new therapeutics for the aging eye.
These strategic appointments signify a significant milestone for BRIJ Medical as they usher in a new era of post-surgical and trauma incision care with proven technologies that minimize wound complications and scarring.
Dr. Eckhard von Keutz has extensive experience in designing and conducting preclinical/toxicological studies, and toxicological risk assessment and management.
David Kroekel has more than 35 years of experience in medical device, combination product operations, and product development.
Dr. Konstantin Kousoulas, a leading virologist will work to further Rational Vaccines core mission of eradicating the world of the herpes simplex virus. "Dr. Kousoulas...

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version